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Generalized Pyoderma Gangrenosum Associated with 
Unrecognized Ulcerative Colitis
Dear Editor, 
We present a case of a 36-year-old female pa-
tient who was initially admitted to the Department 
of Infectious Diseases for evaluation of diarrhea. Two 
years prior to admission, she had been treated in an-
other hospital for erythema nodosum on her calves. 
There was no further diagnosis at that time. The pa-
tient presented with frequent loose stool for three 
weeks before admission to our Department, at the 
time without any bloody tinge present. Four days 
before admittance, the patient’s temperature rose to 
39°C, with bloody loose stools and a C-reactive pro-
tein (CRP) level of 42.8 mg/L. On the fourth day of 
hospitalization, laboratory tests showed anemia and 
erythrocyte sedimentation rate (ESR) of 62 mm/3.6 
ks. The next day, the patient developed generalized 
pyogenous pustules with necrotizing borders on her 
skin. Serologic testing was negative for VDRL, HIV, 
ANA, HBsAg, and HCV antibodies, as well as and RA 
factor. Skin ulcer smear was sterile, and chest X-ray 
and abdominal ultrasound did not reveal any abnor-
mality. Pathohistological analysis of the skin biopsy 
specimen was compatible with pyoderma gangreno-
sum (PG). The dermatologist established a diagnosis 
of severe generalized PG. Stool samples tested nega-
tive for infectious agents. Laboratory tests showed 
progressed anemia, higher leukocyte levels, ESR of 
86 mm/3.6 ks, and CRP level of 151 mg/L. On the 
fourteenth day of hospitalization, a colonoscopy was 
performed and showed that the mucosa of the de-
scending colon and rectum was completely covered 
with ulcerations and pseudopolypous lesions (Figure 
1). The patient was transferred to our Department. 
Pathohistological specimens taken during colonosco-
py were confirmed to be positive for ulcerative colitis 
(UC). Within a few days of the commencement of ap-
propriate treatment, the patient’s general condition 
improved considerably, stool frequency diminished, 
her laboratory parameters (ESR, CRP) regressed, and 
her skin lesions showed significant signs of healing 
(Figure 2). 
PG is a sterile inflammatory neutrophilic dermato-
sis characterized by recurrent cutaneous ulcerations 
with mucopurulent or hemorrhagic exudate (1). Esti-
Figure 1. Colonoscopy image of the patient, per-
formed on day 14.
Figure 2. Generalized skin lesions ten days after be-
ginning of ulcerative collitis treatment.
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mated incidence of PG is 0.63/100000/year (2). About 
50% of PG cases are associated with an underlying 
disorder (1). Inflammatory bowel diseases (IBDs) are 
found in 20% of patients (2). UC is a chronic IBD, caus-
ing uninterrupted mucosal inflammation of the large 
intestine without granulomas on biopsy (3). UC has 
an incidence of 1-20/100000/year and a prevalence of 
6-246/100 000 (4,5), but less than 3% of patients with 
UC develop PG (2). Diagnosis of PG relies primarily on 
clinical signs, and is supported by histopathological 
biopsy (1). It is most often diagnosed by  exclusion of 
other skin disorders (6). After the diagnosis of PG is 
established, it is must be assumed that an underlying 
disease is present, since this is the case in 50% of the 
patients. Feliciani et al. (7) emphasize the importance 
of connecting physical findings with the patient’s his-
tory, and Suárez-Pérez et al. (8) report that patients 
with PG are often referred to dermatologists by other 
specialists after a varying period of time has elapsed 
without achieving an accurate diagnosis. In our case, 
the patient had been treated for erythema nodosum 
two years prior to this episode of generalized PG. She 
was not followed-up after resolution of the condition 
and, since she had only mild abdominal symptoms, 
she had not been further investigated. If our patient 
had been diagnosed with UC after her first skin mani-
festations two years ago, it is possible that the severe 
PG and UC that she presented with could have been 
prevented. Therefore, in patients with skin disorders 
such as PG, routine colonoscopy should be consid-
ered in order to discover an underlying disease such 
as IBDs, so that adequate treatment can be admin-
istered on time, and possible severe extraintestinal 
manifestations can be prevented.
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